10 月 23 日，在中国杭州举行的 2025 IEEE/RSJ 智能机器人与系统国际会议（ IROS 2025 ）上，元化智 能科技（深圳）有限公司首席科学家、南方科技大学讲席教授孟庆虎院士荣获 IROS Harashima Award for Innovative Technologies （创新技术奖），成为该奖项自 2007 年设立以来的第十二位获奖者，同时也是 中国大陆学者首位获此殊荣的科学家。 IROS Harashima Award 是国际智能机器人与系统领域最具权威性的个人荣誉之一，旨在表彰在机器人与智 能系统方向作出开创性贡献的杰出科学家。该奖项由国际机器人学术界权威专家委员会严格评选，代表全球机 器人技术创新的最高水准。孟庆虎院士此次获奖，是对其在医疗机器人与服务机器人领域的感知与智能技术方 面取得卓越成就的高度认可。 ▍ 推动 IROS 发展，助力中国成为全球机器人创新中心 作为中国机器人学术界的领军人物之一，孟庆虎院士长期致力于推动国际学术交流与技术进步。 2005 年， 他与张宏院士共同主办 IROS 2005 ，当时参会人数约 800 人；而 2025 年在杭州举办的 IROS 大 ...

Core Viewpoint - The company, Giant Shark Medical Technology Co., Ltd., has made significant advancements in the medical equipment sector through self-research and development, focusing on high-quality and technologically advanced medical devices, which are now exported to over 100 countries and regions [1][2]. Group 1: Company Overview - Giant Shark Medical was established in 1996, initially acting as a trade agent for imported medical equipment in China [1]. - The company has applied for over 1,000 international and domestic patents and has received multiple recognitions, including being a national high-tech enterprise and a national specialized "little giant" enterprise [1]. Group 2: Research and Development - The R&D team has increased its employee proportion to over 30% and invests more than 10% of annual revenue into R&D [2]. - The company has developed a 32M ultra-high-resolution color medical diagnostic display screen, improving resolution from 2 million pixels to 32 million pixels, enhancing early detection of small lesions [2]. Group 3: Market Strategy - To overcome negative perceptions of domestic brands in international markets, the company focuses on high product quality and competitive pricing compared to foreign counterparts [2]. - The company has established R&D centers in Nanjing, Shanghai, and Shenzhen, and has formed partnerships with several universities for collaborative research [2]. Group 4: Future Plans - The company aims to continue its focus on technological innovation, developing more advanced medical products to become a global high-tech medical enterprise [3].